13 NONCLINICAL TOXICOLOGY 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility In a 2-year carcinogenicity study in CD-1 mice, subcutaneous doses of 0.3, 1 and 3 mg/kg/day [5-, 17-, and 59-fold the maximum recommended human dose (MRHD) of 1 mg/week, based on AUC] were administered to the males, and 0.1, 0.3 and 1 mg/kg/day (2-, 5-, and 17-fold MRHD) were administered to the females
Mitochondria as multifaceted regulators of ferroptosis
Maintenance & Tone Correction (90k 120k MG) Royal Gold (120,000mg) Best For: Correcting stubborn dark spots and achieving a premium, luminous finish
Meto's resources on metabolic syndrome and fatty liver disease provide relevant context for why VAT reduction translates to systemic metabolic benefit